IGFBP2 and systemic sclerosis: Indeed, the serum levels of IGFBP-2 were shown to be elevated in SSc patients with lung vascular involvement compared to healthy donors, and of remarkable importance were observations that IGFBP-2 levels displayed a negative correlation with pulmonary function in these patients [41].